Chargement en cours...
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
Type 2 diabetes has become a major burden to the health care systems worldwide. Among the drugs approved for this indication, glimepiride and rosiglitazone have gained substantial importance in routine use. While glimepiride stimulates β-cell secretion and leads to reduction of blood glucose values,...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1994031/ https://ncbi.nlm.nih.gov/pubmed/17580731 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|